Inventor · disambiguated record
Anja Giese
Also filed as: GIESE ANJA
2 granted patents·8 pending applications·1 citations·filing 2015–2021
30Inventor score
Top patents by PatentIndex Score
10 records- 0166US10487092B2Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·1 cites·22 claims
- 0259US2023065629A1Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 0351US11208400B2Substituted 6-(1H-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereofBAYER AG·Filed 2017·Granted Dec 28, 2021·0 cites·17 claims
- 0433US2018044306A11,3,4-thiadiazol-2-yl-benzamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 0533US2018042931A1N-phenyl-(morpholin-4-yl or piperazinyl)acetamide derivatives and their use as inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2016·Application pending·0 cites
- 0633US2018028507A13-carbamoylphenyl-4-carboxamide and isophtalamide derivatives as inhibitors of the wnt signalling pathwayBayer Pharma AG·Filed 2016·Application pending·0 cites
- 0732US2017107229A1Substituted tetrahydropyridothienopyrimidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 0832US2017197979A1BenzothiadiazolaminesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 0931US2017107212A1Novel compoundsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 1031US2017114070A1Inhibitors of the wnt signalling pathwaysBayer Pharma AG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →